XBiotech (XBIT) Competitor Comparison
We are evaluating the key criteria listed to compare XBiotech (XBIT) against its competitors in the Biotechnology industry.
Market Capitalization
229 / 368Gross Profits
111 / 278Total Revenue
264 / 300EBITDA
120 / 337Free Cashflow
119 / 352Quick Ratio
4 / 357Earnings per Share
147 / 359Dividend yield
0 / 6Total Cash
155 / 358Performance 3 years
157 / 368Performance 5 years
174 / 368Performance 10 years
183 / 368Linearity 3 years
124 / 368Linearity 5 years
83 / 368Linearity 10 years
166 / 368Total Rank
69 / 368Dividend Rank
16 / 368Valuation Rank
246 / 368Piotroski Rank
321 / 368Muliplier Rank
239 / 368Performance 3 years - XBIT ranking 157 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.